Background: In this study the analytical performance of eight glucose point-of-care testing (POCT) devices was evaluated. For this purpose, POCT measurement of glucose in heparinized blood collected from patients was paralleled by determination of the glucose concentration in the respective plasma by an analyzer (Hitachi 917) in the central laboratory, providing traceable results.
Methods: Trueness of POCT measurements was studied by comparing the plasma POCT values (mean of five measurements) with the results from the traceable measurement procedure (TMP).
Results: The percentage of POCT results within ±6% of the TMP mean value ranged from 24% to 50%, depending on the POCT device. Within the reference interval of plasma glucose (4.4–6.0mmol/L), up to 67% of the POCT values were lower than 4.4mmol/L, leading to a false diagnosis of hypoglycemia. In the hypoglycemic range (<4.4mmol/L) up to 29% of the POCT analyses were false normoglycemic.
Conclusions: In conclusion, this study shows an insufficient trueness of glucose measurements by POCT devices in the normo- and hypoglycemic range. To improve quality assessment, sample splitting and simultaneous measurement of blood glucose concentration every 4weeks by POCT devices and of plasma glucose concentration by a reliable TMP is recommended.
Clin Chem Lab Med 2006;44:888–93.
1. D'Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, et al. Approved IFCC recommendation on reporting results for blood glucose [abbreviated]. Clin Chem 2005; 51:1573–6.10.1373/clinchem.2005.051979Search in Google Scholar
2. Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen 2001. Dt Ärztebl 2001;98:A2747–59, ibid 2002;99:A1187, ibid 2003;100:A3335–8.Search in Google Scholar
3. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26:(Suppl 1):S33–50.10.2337/diacare.26.2007.S33Search in Google Scholar
4. Maser RE, Butler MA, DeCherney GS. Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate? Crit Care Med 1994; 22:595–9.10.1097/00003246-199404000-00014Search in Google Scholar
5. Kost GJ, Vu HT, Lee JH, Bourgeois P, Kiechle FL, Martin C, et al. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 1998; 26:581–90.10.1097/00003246-199803000-00036Search in Google Scholar
6. Fogh-Andersen N, D'Orazio P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem 1998; 44:655–9.10.1093/clinchem/44.3.655Search in Google Scholar
7. Hannestad U, Lundblad A. Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clin Chem 1997; 5:794–800.10.1093/clinchem/43.5.794Search in Google Scholar
8. Siggard-Andersen O, Durst RA, Maas AH. Physiochemical quantities and units in clinical chemistry with special emphasis on activities and activity coefficients. IUPAC/IFCC recommendation. J Clin Chem Clin Biochem 1987; 25:369–91, Ann Biol Clin 1987; 45:89–109.Search in Google Scholar
9. Fogh-Andersen N, Wimberley PD, Thode J, Siggard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clin Chim Acta 1990; 189:33–8.10.1016/0009-8981(90)90232-HSearch in Google Scholar
10. Ho HT, Yeung WK, Young BW. Evaluation of point of care devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal 2004; 89:F356–9.10.1136/adc.2003.033548Search in Google Scholar PubMed PubMed Central
©2006 by Walter de Gruyter Berlin New York